Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Animal Models

Curcumin enhances the anti-obesogenic activity of orlistat through SKN-1/NRF2-dependent regulation of nutrient metabolism in Caenorhabditis elegans

Abstract

Background

Metabolic dysregulation, a defining feature of obesity, disrupts essential signalling pathways involved in nutrient sensing and mitochondria homeostasis. The nuclear factor erythroid 2-related factor 2 (NRF-2) serves as a pivotal regulator of the cellular stress response, and recent studies have implicated it in the pathogenesis of obesity, diabetes, and metabolic syndrome. Curcumin, a polyphenolic compound derived from turmeric, has been identified as a potent activator of NRF-2. Evidence suggests curcumin impacts obesity and metabolic disorders by modulating gut microbiota composition, increasing energy expenditure, and regulating lipid metabolism. Orlistat, an anti-obesity drug, inhibits fat absorption in the gastrointestinal tract, but its side effects limits its broader use.

Objectives

The present study aims to investigate the potential synergetic effect of a hybrid combination between orlistat and curcumin. Additionally, we provide a detailed understanding of the molecular mechanisms through which this combination mitigates glucose-induced lipid accumulation in Caenorhabditis elegans, with a focus on the role of the skinhead 1 (SKN-1) transcription factor, an orthologue of NRF2.

Methods

We assessed the lipid accumulation and the changes in skn-1 transcriptional activity in C. elegans using confocal GFP-based detection, alongside mRNA expression analysis of genes from lipid metabolism and oxidative stress response in wild-type, QV225 and LD1 strains. Furthermore, we evaluated locomotion, chemotaxis and mitochondrial dynamics to enhance our understanding of the proposed molecular-based model.

Results

Our findings reveal that the orlistat/curcumin combination exerts an anti-obesogenic effect through SKN-1/NRF2-dependent regulation of conserved genes involved in carbohydrate and lipid metabolism in C. elegans. Moreover, the combination stimulates mitochondrial potential, further contributing to the observed synergistic effects.

Conclusion

The hybrid combination of orlistat and curcumin demonstrates significant anti-obesity activity by regulating nutrient-sensing pathways through SKN-1/NRF-2 modulation. This approach may allow for the reduction of orlistat dosage, thereby minimizing its adverse effects while maintaining its therapeutic efficacy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Curcumin and orlistat combination stimulates the chemosensory system and body bending in glucose-fed C. elegans.
Fig. 2: Curcumin and orlistat combination potently suppressed glucose-associated lipid accumulation in C. elegans.
Fig. 3: Curcumin and orlistat combination upregulates SKN-1 expression in glucose-supplemented C. elegans.
Fig. 4: Curcumin and orlistat modulate genes related to the nutrient-sensing network in C. elegans-based obesity model.
Fig. 5: Curcumin and orlistat either alone or in combination stimulate mitochondrial potential in glucose-supplemented C. elegans.
Fig. 6: Orlistat/curcumin combination regulates lipid metabolism and mitochondria activity through skn-1 activation in C. elegans.

Similar content being viewed by others

Data availability

All relevant data are within the manuscript. The data set generated and analysed during the current study also available from the corresponding author upon request.

References

  1. Wen X, Zhang B, Wu B, Haitao X, Zehua L, Ruoyu L, et al. Signalling pathways in obesity: mechanisms and therapeutic interventions. Sign Transduct Target Ther. 2022;7:298.

    Article  Google Scholar 

  2. Phelps NH, Singleton RK, Zhou B, Heap RA, Mishra A, Bennett JE, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403:1027–50.

    Article  Google Scholar 

  3. Savova MS, Mihaylova LV, Tews D, Wabitsch M, Georgiev MI. Targeting PI3K/AKT signaling pathway in obesity. Biomed Pharmacother. 2023;159:114244.

    Article  CAS  PubMed  Google Scholar 

  4. Muller TD, Blüher M, Tschöp MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2022;21:201–23.

    Article  PubMed  Google Scholar 

  5. Zhao XY, Wang JQ, Neely GG, Shi YC, Wang QP. Natural compounds as obesity pharmacotherapies. Phytother Res. 2024;38:797–838.

    Article  CAS  PubMed  Google Scholar 

  6. Holmback U, Grudén S, Litorp H, Willhems D, Kuusk S, Alderborn G, et al. Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial. Obesity. 2022;30:2222–32.

    Article  CAS  PubMed  Google Scholar 

  7. Longo VD, Di Tano M, Mattson MP, Guidi N. Intermittent and periodic fasting, longevity and disease. Nat Aging. 2021;1:47–59.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Weir HJ, Yao P, Huynh FK, Escoubas CC, Goncalves RL, Burkewitz K, et al. Dietary restriction and AMPK increase lifespan via mitochondrial network and peroxisome remodelling. Cell Metab. 2017;26:884–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Madeo F, Carmona-Gutierrez D, Hofer SJ, Kroemer G. Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential. Cell Metab. 2019;29:592–610.

    Article  CAS  PubMed  Google Scholar 

  10. Wei M, Brandhorlistat S, Shelehchi M, Mirzaei H, Cheng CW, Budniak J, et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med. 2017;15:eaai8700.

    Article  Google Scholar 

  11. Atanasov AG, Zotchev SB, Dirsch VM, Orhan IE, Banach M, Rollinger JM, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20:200–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Thomas C, Erni R, Wu JY, Fischer F, Lamers G, Grigolon G, et al. A naturally occurring polyacetylene isolated from carrots promotes health and delays signatures of aging. Nat Commun. 2023;14:8142.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Bolger GT, Pucaj K, Minta YO, Sordillo P. Relationship between the in vitro efficacy, pharmacokinetics and in vivo efficacy of curcumin. Biochem Pharmacol. 2022;205:115251. https://doi.org/10.1016/j.bcp.2022.115251.

    Article  CAS  PubMed  Google Scholar 

  14. Vasileva LV, Saracheva KE, Ivanovska MV, Petrova AP, Marchev AS, Georgiev MI, et al. Antidepressant-like effect of salidroside and curcumin on the immunoreactivity of rats subjected to a chronic mild stress model. Food Chem Toxicol. 2018;121:604–11.

    Article  CAS  PubMed  Google Scholar 

  15. Shin JW, Chun KS, Kim DH, Kim SJ, Kim SH, Cho NC, et al. Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification. Biochem Pharmacol. 2020;173:113820.

    Article  CAS  PubMed  Google Scholar 

  16. Ren L, Zhan P, Wang Q, Wang C, Liu Y, Yu Z, et al. Curcumin upregulates the Nrf2 system by repressing inflammatory signalling-mediated Keap1 expression in insulin-resistant conditions. Biochem Biophys Res Commun. 2019;514:691–8.

    Article  CAS  PubMed  Google Scholar 

  17. Li N, Yan X, Huang W, Chu M, Dong Y, Song H, et al. Curcumin protects against the age-related hearing loss by attenuating apoptosis and senescence via activating Nrf2 signaling in cochlear hair cells. Biochem Pharmacol. 2023;212:115575.

    Article  CAS  PubMed  Google Scholar 

  18. Wu X, Zhou X, Lai S, Liu J, Qi J. Curcumin activates Nrf2/HO-1 signaling to relieve diabetic cardiomyopathy injury by reducing ROS in vitro and in vivo. FASEB J. 2022;36:e22505.

    Article  CAS  PubMed  Google Scholar 

  19. Sampath C, Wilus D, Tabatabai M, Freeman ML, Gangula PR. Mechanistic role of antioxidants in rescuing delayed gastric emptying in high fat diet induced diabetic female mice. Biomed Pharmacoth. 2021;137:111370.

    Article  CAS  Google Scholar 

  20. Vasileva LV, Savova MS, Amirova KM, Dinkova-Kostova AT, Georgiev MI. Obesity and NRF2-mediated cytoprotection: Where is the missing link? Pharmacol Res. 2020;156:104760.

    Article  CAS  PubMed  Google Scholar 

  21. Paek J, Jacqueline YL, Naracimhan SD, Nguyen TN, Glover-Cutter K, Robida-Stubbs S, et al. Mitochondrial SKN-1/Nrf mediates a conserved starvation response. Cell Metab. 2012;16:526–3.

  22. Frankino PA, Siddiqi TF, Bolas T, Bar-Ziv R, Gildea HK, Zhang H, et al. SKN-1 regulates stress resistance downstream of amino catabolism pathways. iScience. 2022;25:104571.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pang S, Lynn D, Lo J, Paek J, Curran SP. SKN-1 and Nrf2 couples proline catabolism with lipid metabolism during nutrient deprivation. Nat Commun. 2014;5:5048.

    Article  CAS  PubMed  Google Scholar 

  24. Blackwell TK, Steinbaugh MJ, Hourihan JM, Ewald CY, Isik M. SKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans. Free Radic Biol Med. 2015;88:290–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Costa RM, Dias MC, Alves JV, Silva JLM, Rodrigues D, Silva JF, et al. Pharmacological activation of nuclear factor erythroid 2-related factor-2 prevents hyperglycemia-induced renal oxidative damage: Possible involvement of O-GlcNAcylation. Biochem Pharmacol. 2024;220:115982.

    Article  CAS  PubMed  Google Scholar 

  26. Steinbaugh MJ, Narasimhan SD, Robida-Stubbs S, Moronetti Mazzeo LE, Dreyfuss JM, Hourihan JM, et al. Lipid-mediated regulation of SKN-1/Nrf in response to germ cell absence. eLife. 2015;4:e07836.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Dou Y, Huang R, Li Q, Liu Y, Li Y, Chen H, et al. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signalling pathways. Biomed Pharmacother. 2021;137:111312.

    Article  CAS  PubMed  Google Scholar 

  28. Gao W, Wang W, Zhang J, Deng P, Hu J, Yang J, et al. Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX/Nrf2 imbalance in mice. Metab Brain Dis. 2019;34:1267–80.

    Article  CAS  PubMed  Google Scholar 

  29. Islam MT, Tuday E, Allen S, Kim J, Trott DW, Holland WL, et al. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age. Aging Cell. 2023;22:e13767.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Novais EJ, Tran VA, Johnston SN, Darris KR, Roupas AJ, Sessions GA, et al. Long-term treatment with senolytic drugs dasatinib and quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat Commun. 2021;12:5213.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Huang SL, Chang TC, Sun NK. Curcumin reduces paclitaxel resistance in ovarian carcinoma cells by upregulating SNIP1 and inhibiting NFκB activity. Biochem Pharmacol. 2023;212:115581.

    Article  CAS  PubMed  Google Scholar 

  32. Chen B, He Q, Chen C, Lin Y, Xiao J, Pan Z, et al. Combination of curcumin and catalase protects against chondrocyte injury and knee osteoarthritis progression by suppressing oxidative stress. Biomed Pharmacoth. 2023;168:115751.

    Article  CAS  Google Scholar 

  33. Li WJ, Wang CW, Tao L, Yan YH, Zhang MJ, Liu ZX, et al. Insulin signalling regulates longevity through protein phosphorylation in Caenorhabditis elegans. Nat Commun. 2021;12:4568.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Shen P, Yue Y, Park Y. A living model for obesity and aging research: Caenorhabditis elegans. Crit Rev Food Sci Nutr. 2018;58:741–54.

    Article  PubMed  Google Scholar 

  35. Mora I, Puiggròs F, Serras F, Gil-Cardoso K, Escoté X. Emerging models for studying adipose tissue metabolism. Biochem Pharmacol. 20214;223:116123.

  36. Yue Y, Hao G, Cho J, Park Y. Curcumin reduced fat accumulation in Caenorhabditis elegans. Curr Res Food Sci. 2021;4:551–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Bai J, Farias‐Pereira R, Zhang Y, Jang M, Park Y, Kim HK. C. elegans ACAT regulates lipolysis and its related lifespan in fasting through modulation of the genes in lipolysis and insulin/IGF-1 signalling. BioFactors. 2020;46:754–65.

    Article  CAS  PubMed  Google Scholar 

  38. Michaeli L, Spector E, Haeussler S, Carvalho CA, Grobe H, Abu-Shach UB, et al. ULP-2 SUMO protease regulates UPRmt and mitochondrial homeostasis in Caenorhabditis elegans. Free Radic Biol Med. 2024;214:19–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Navarro-Hortal MD, Romero-Márquez JM, Esteban-Muñoz A, Sánchez-González C, Rivas-García L, Llopis L, et al. Strawberry (Fragaria×ananassa cv. Romina) methanolic extract attenuates Alzheimer’s beta amyloid production and oxidative stress by SKN-1/NRF and DAF-16/FOXO mediated mechanisms in C. elegans. Food Chem. 2022;372:131272.

    Article  CAS  PubMed  Google Scholar 

  40. An JH, Blackwell TK. SKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response. Genes Dev. 2003;17:1882–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Aranaz P, Navarro-Herrera D, Romo-Hualde A, Miguel L, Vizmanos L, Milagro I. Phenolic compounds reduce the fat content in Caenorhabditis elegans by affecting lipogenesis, lipolysis, and different stress responses. Pharmaceuticals. 2020;13:355.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Savova MS, Todorova MN, Apostolov AG, Yahubyan GT, Georgiev MI. Betulinic acid counteracts the lipid accumulation in Caenorhabditis elegans by modulation of nhr-49 expression. Biomed Pharmacother. 2022;156:113862.

    Article  CAS  PubMed  Google Scholar 

  43. Mladenova SG, Todorova MN, Savova MS, Georgiev MI, Mihaylova LV. Maackiain mimics caloric restriction through aak-2-mediated lipid reduction in Caenorhabditis elegans. Int J Mol Sci. 2023;24:17442.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Todorova MN, Savova MS, Mihaylova LV, Georgiev MI. Icariin improves stress resistance and extends lifespan in Caenorhabditis elegans through hsf-1 and daf-2-driven hormesis. Int J Mol Sci. 2024;25:352.

    Article  CAS  Google Scholar 

  45. Queiros L, Marques C, Pereira JL, Gonçalves FJM, Aschner M, Pereira P. Overview of chemotaxis behavior assays in Caenorhabditis elegans. Curr Protoc. 2021;1:e120.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Stuhr N, Nhan J, Hammerquist A, Van Camp B, Reoyo D, Curran S. Rapid lipid quantification in Caenorhabditis elegans by oil red O and Nile red staining. Bio Protoc. 2022;12:e4340.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Berry BJ, Vodičková A, Müller-Eigner A, Meng C, Ludwig C, Kaeberlein M, et al. Optogenetic rejuvenation of mitochondrial membrane potential extends C. elegans lifespan. Nat Aging. 2023;3:157–61.

    Article  PubMed  Google Scholar 

  48. Pai SA, Munshi RP, Panchal FH, Gaur IS, Mestry SN, Gursahani MS, et al. Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress. Biomed Pharmacother. 2019;111:686–94.

    Article  CAS  PubMed  Google Scholar 

  49. Nunez S, Moliner C, Valero MS, Mustafa AM, Maggi F, Gómez-Rincón C, et al. Antidiabetic and anti-obesity properties of a polyphenol-rich flower extract from Tagetes erecta L. and its effects on Caenorhabditis elegans fat storages. J Physiol Biochem. 2023;79:427–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Lin C, Lin Y, Chen Y, Xu J, Li J, Cao Y, et al. Effects of: Momordica saponin extract on alleviating fat accumulation in Caenorhabditis elegans. Food Funct. 2019;10:3237–51.

    Article  CAS  PubMed  Google Scholar 

  51. Chen Y, Qin Q, Luo J, Dong Y, Lin C, Chen H, et al. Litchi flower essential oil balanced lipid metabolism through the regulation of DAF-2/IIS, MDT-15/SBP-1, and MDT-15/NHR-49 pathway. Front Nutr. 2022;9:934518.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Goh GYS, Winter JJ, Bhanshali F, Doering KRS, Lai R, Lee K, et al. NHR-49/HNF4 integrates regulation of fatty acid metabolism with a protective transcriptional response to oxidative stress and fasting. Aging Cell. 2018;17:e12743.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Li Y, Ding W, Li CY, Ying L. HLH-11 modulates lipid metabolism in response to nutrient availability. Nat Commun. 2020;11:5959.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Inoue H, Hisamoto N, AnJH, Oliveira RP, Nishida E, Blackwell TK, et al. The C. elegans p38 MAPK pathway regulates nuclear localization of the transcription factor SKN-1 in oxidative stress response. Genes Dev. 2005;19:2278–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Lee D, Jeong DE, Son HG, Yamaoka Y, Kim H, Seo K, et al. SREBP and MDT-15 protect C. elegans from glucose-induced accelerated aging by preventing accumulation of saturated fat. Genes Dev. 2015;29:2490–503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Zhang Y, Lanjuin A, Chowdhury SR, Mistry M, Silva-García CG, Weir HJ, et al. Neuronal TORC1 modulates longevity via AMPK and cell nonautonomous regulation of mitochondrial dynamics in C. elegans. eLife. 2019;8:e49158.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Bakar MHA, Shariff KA, Tan JS, Lee LK. Celastrol attenuates inflammatory responses in adipose tissues and improves skeletal muscle mitochondrial functions in high fat diet-induced obese rats via upregulation of AMPK/SIRT1 signalling pathways. Eur J Pharmacol. 202;883:173371.

  58. Guo X, García LR. SIR-2.1 integrates metabolic homeostasis with the reproductive neuromuscular excitability in early aging male Caenorhabditis elegans. eLife. 2014;3:e01730.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Statzer C, Meng J, Venz R, Bland M, Robida-Stubbs R, Patel K, et al. ATF-4 and hydrogen sulfide signalling mediate longevity in response to inhibition of translation or mTORC1. Nat Commun. 2022;13:967.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Farias-Pereira R, Savarese J, Yue Y, Lee SH, Park Y. Fat-lowering effects of isorhamnetin are via NHR-49-dependent pathway in Caenorhabditis elegans. Curr Res Food Sci. 2019;2:70–76.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research received funding from the Bulgarian National Science Fund under BG-175467353-2023-03 programme for project Natural NRF2 activators modulating obesity mechanisms: molecular pharmacology-based in vivo study (contract number КП-06-КОСТ/4), the European Union’s Horizon 2020 research and innovation programme, project PlantaSYST (SGA No 739582 under FPA No. 664620) and by the European Regional Development Fund through the Bulgarian “Science and Education for Smart Growth” Operational Programme (project BG05M2OP001-1.003-0001-C01) and Programme Research Innovation and Digitalisation for Smart Transformation. This article is based upon work from COST Action CA20121 BenBedPhar, supported by COST (European Cooperation in Science and Technology).

Author information

Authors and Affiliations

Authors

Contributions

Martina S. Savova: Conceptualization, Methodology, Formal analysis, Data curation, Writing – original draft, review and editing. Monika N. Todorova: Conceptualization, Methodology, Data curation, Writing – original draft, Visualization, Investigation. Biser K. Binev: Methodology. Milen I. Georgiev: Conceptualization, Methodology, Supervision, Funding acquisition, Writing – review and editing. Liliya V. Mihaylova: Conceptualization, Methodology, Formal analysis, Writing – review and editing, Funding acquisition, Supervision.

Corresponding author

Correspondence to Liliya V. Mihaylova.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

This study does not involve human participants, human material, or live vertebrates. The research was conducted using C. elegans as a model organism, which aligns with the Replacement principle of the 3 R’s (Replacement, Reduction and Refinement) philosophy. Therefore, ethics approval or consent to participate were not required.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Savova, M.S., Todorova, M.N., Binev, B.K. et al. Curcumin enhances the anti-obesogenic activity of orlistat through SKN-1/NRF2-dependent regulation of nutrient metabolism in Caenorhabditis elegans. Int J Obes 49, 516–526 (2025). https://doi.org/10.1038/s41366-025-01724-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41366-025-01724-6

This article is cited by

Search

Quick links